WC
BCAB

Wexford Capital’s BIOATLA INC BCAB Stock Holding History

Wexford Capital’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-237
Closed -$29.1K – 216
2023
Q4 		$29.1K Buy
+237
New +$20.5K 0.01% 162

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wexford Capital's BCAB Position: Q1 2024 in Review

Wexford Capital sold out of BIOATLA INC (BCAB) in Q1 2024, closing a stake of 237 shares — an estimated $29.1K sold.

Wexford Capital first reported a position in BCAB in Q4 2023 and held it in 1 quarter. The position peaked at $29.1K in Q4 2023. 82 funds tracked by Wall St. Rank hold BCAB as of Q1 2024.

  • Wexford Capital reported no remaining BIOATLA INC position as of Q1 2024 after selling out during the quarter.
  • Wexford Capital sold 237 BIOATLA INC shares in Q1 2024, an estimated $29.1K.
  • Wexford Capital first reported a position in BIOATLA INC in Q4 2023 and held it in 1 quarter.
  • Wexford Capital's BIOATLA INC position peaked at $29.1K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held BIOATLA INC as of Q1 2024.

Based on Wexford Capital's 13F filing for Q1 2024, filed 15 May 2024.